MoneyWorks4Me

NGL Fine-Chem informs about material impact of covid-19 pandemic

09 Jul 2020 Evaluate

NGL Fine-Chem has informed that pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular No: SEBI/HO/CFD/CMDI/CIR/P/2020/84 dated May 20, 2020, the disclosure of material impact of COVID-19 pandemic on the Company’s operation & performance is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..